PROCLAIM-CX-072: Monotherapy for advanced triple negative breast cancer with skin metastases in a phase 1-2 trial of the PD-L1 probody therapeutic CX-072S. Adams,E. Hamilton,P. A. Ott,D. Cho,K. Kalinsky,P. LoRusso, M. Will, V. Huels,B. Benson, C. Murias,H-T ArkenauCANCER RESEARCH（2019）引用 1|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
